MAP Pharmaceuticals, Inc.

• About Us 
  • Message from the CEO
  • Management Team
  • Board of Directors
  • Partnering
  • Contact Us
• Product Pipeline 
  • Pediatric Asthma Therapy
  • Inhaled Migraine Therapy
  • Asthma/COPD Therapy
  • Inhaled Diabetes Therapy
• Investor Relations 
  • IR Home
  • Press Releases
  • Calendar of Events
  • Corporate Governance
  • Management
  • Board of Directors
  • Committee Composition
  • Annual Reports
  • SEC Filings
  • Stock Information
  • Analyst Coverage
  • Contact Us
• Science & Technology 
• Publications 
  • Asthma
  • Migraine
  • Aerosol Science and Technology

Investor Relations

Print page     Email page

SEC Filings

View: All Filings Annual Quarterly Current Section 16 Proxy Other    Year: All Years 2008 2007

Filing	Description	Date Filed	Size
8-K	current report	Jul 14, 2008	36.4 KB
4	gianakakos, anastasios	Jul 8, 2008	27.3 KB
4	gianakakos, anastasios	Jul 7, 2008	29.3 KB
4	gianakakos, anastasios	Jul 7, 2008	33.2 KB
4	gianakakos, anastasios	Jul 2, 2008	28.9 KB
8-K	current report	Jun 24, 2008	41.0 KB
CT ORDER	confidential treatment order	Jun 19, 2008	12.8 KB
4	gianakakos, anastasios	Jun 5, 2008	30.5 KB
4	gianakakos, anastasios	Jun 4, 2008	32.2 KB
4	gianakakos, anastasios	Jun 3, 2008	33.8 KB
4	pearl, frank h	May 27, 2008	27.0 KB
4	soros, george	May 27, 2008	29.3 KB
4	mcpherron, matthew v	May 22, 2008	24.6 KB
4	freund, john gordon	May 22, 2008	24.7 KB
4	elms, steve	May 22, 2008	25.2 KB
4	goldfischer, carl	May 22, 2008	24.5 KB
4	henwood, geraldine	May 22, 2008	24.7 KB
4	kelley, bernard j	May 22, 2008	24.7 KB
4	gianakakos, anastasios	May 20, 2008	34.8 KB
4	gianakakos, anastasios	May 20, 2008	30.9 KB
Showing 1-20 of 90 Page: 1 2 3 ... 5  Next 20

= add filing to Briefcase

Stock Information

NASD:MAPP $9.20	+ 0.10
Jul 23, 2008	4:10 PM ET

Quotes delayed at least 20 minutes.
Information provided by TurboFeed.